- Topics
- Regions
- Events
- Webcasts
- Resources
- CW Exclusives
- Membership
“For tracking litigation, enforcement, and regulatory developments, Compliance Week
should be your prime source.”- Chief Compliance Officer and VP of Legal Affairs, Arrow Electronics
Justice Department Intervenes in Whistleblower Suits Against Omnicare
The Justice Department recently intervened in two consolidated whistleblower lawsuits against drug company Omnicare over allegations that it solicited and received millions of dollars in kickbacks from drug maker Abbott Laboratories. “Although the U.S. Attorney’s Office for the Western District of Virginia is small, we will not waver in our ...
THIS IS MEMBERS-ONLY CONTENT
You are not logged in and do not have access to members-only content.
If you are already a registered user or a member, SIGN IN now.
Related articles
-
ArticleAlleged compliance failures at Omnicare lead to healthcare fraud lawsuit
A series of alleged compliance failures at pharmaceutical services provider Omnicare has resulted in the Department of Justice intervening in yet another civil healthcare fraud lawsuit against the company.
-
PremiumExperts: U.K. digital market reforms a ‘watershed moment,’ could speed up enforcement
The U.K.’s competition regulator has outlined new plans to regulate Big Tech firms that will enable it to take a much more flexible and proactive approach towards investigations.
-
News BriefCFPB issues $2.5M penalty against Wise in last action of Chopra era
A fine by the Consumer Financial Protection Bureau (CFPB) against the U.S arm of London-based foreign exchange company Wise could be one of the agency’s final actions as a new regulatory regime reportedly froze rules and litigation amid calls for defunding.